Margot Pont, PhD is Director and Head of Translational Science EU at Galapagos, where she leads biomarker strategy and translational development for CAR-T and TCR-T cell therapy programs in both solid tumors and hematologic malignancies. With 15 years of experience in academic and biotech settings—including pivotal work at Fred Hutchinson Cancer Research Center and early leadership at CellPoint—Margot has helped shape programs from concept through IND and first-in-human trials. Passionate about bridging science and strategy, she thrives on building teams and translating immunology into real-world therapies.